Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 3/20 | 0.38 |
| ▸ | RET | P07949 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.37 |
| ▸ | HPGDS | O60760 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6284635 | 0.80 | KMT2A (0.49) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL6284446 | 0.79 | KMT2A (0.51) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL471729 | 0.79 | ALDH1A1 (0.50) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL6107954 | 0.77 | KDM4E (0.42) | KMT2AALDH1A1KDM4ELMNAPOLB | |
| SCHEMBL22030392 | 0.77 | ALDH1A1 (0.49) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL11419796 | 0.77 | KMT2A (0.49) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL15964104 | 0.77 | KMT2A (0.57) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL13236669 | 0.76 | ALDH1A1 (0.50) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL16588388 | 0.76 | KMT2A (0.48) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL7767345 | 0.76 | KMT2A (0.41) | KMT2ARAB9AALDH1A1KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200269187-A1 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2020-08-27 | — | — | US | claimed |
| EP-3678756-A1 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | BASF SE (DE) | 2020-07-15 | — | — | EP | claimed |
| CN-111093803-A | Absorbent and process for selective removal of hydrogen sulfide | 巴斯夫欧洲公司 | 2020-05-01 | — | — | CN | claimed |
| WO-2019043099-A1 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | BASF SE (DE) | 2019-03-07 | — | — | WO | claimed |
| US-11458433-B2 | Absorbent and process for selectively removing hydrogen sulfide | BASF SE (DE) | 2022-10-04 | — | — | US | disclosed |
| CN-111093803-B | Absorbent and process for selective removal of hydrogen sulfide | 巴斯夫欧洲公司 | 2022-06-24 | — | — | CN | disclosed |
| EP-3678756-B1 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | BASF SE (DE) | 2021-06-30 | — | — | EP | disclosed |
| US-20200269187-A1 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2020-08-27 | — | — | US | disclosed |
| EP-3678756-A1 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | BASF SE (DE) | 2020-07-15 | — | — | EP | disclosed |
| CN-111093803-A | Absorbent and process for selective removal of hydrogen sulfide | 巴斯夫欧洲公司 | 2020-05-01 | — | — | CN | disclosed |
| WO-2019043099-A1 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | BASF SE (DE) | 2019-03-07 | — | — | WO | disclosed |
| US-9580415-B2 | Compounds | PROXIMAGEN LIMITED (GB) | 2017-02-28 | — | — | US | disclosed |
| US-20090192177-A1 | 2-ARYL pyrrologpyrimidines for A1 and A3 receptors | OSI PHARMACEUTICALS, INC. | 2009-07-30 | — | — | US | disclosed |
| US-20090082369-A1 | Pyrrolo[2,3d]pyrimidine compositions and their use | OSI PHARMACEUTICALS, INC. | 2009-03-26 | — | — | US | disclosed |
| US-7504407-B2 | Compounds specific to adenosine A1 and A3 receptors and uses thereof | OSI PHARMACEUTICALS, INC. (US) | 2009-03-17 | — | — | US | disclosed |
| US-7429574-B2 | 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use | OSI PHARMACEUTICALS, INC. (US) | 2008-09-30 | — | — | US | disclosed |
| US-20080070936-A1 | Compounds specific to adenosine A1 receptors and uses thereof | OSI PHARMACEUTICALS, INC. | 2008-03-20 | — | — | US | disclosed |
| US-20080070936-A1 | Compounds specific to adenosine A1 receptors and uses thereof | OSI PHARMACEUTICALS, INC. | 2008-03-20 | — | — | US | disclosed |
| US-7160890-B2 | Compounds specific to adenosine A3 receptor and uses thereof | OSI PHARMACEUTICALS, INC. (US) | 2007-01-09 | — | — | US | disclosed |
| US-6680324-B2 | 4-AMINO-6-PHENYL-PYRROLO(2,3-D)PYRIMIDINE DERIVATIVES | OSI PHARMACEUTICALS, INC. | 2004-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090192177-A1 | 2-ARYL pyrrologpyrimidines for A1 and A3 receptors | ADORA3, ADORA1, ADORA2A | KMT2A 2686/4885RAB9A 2270/4885ALDH1A1 265/4885 |
| US-20090082369-A1 | Pyrrolo[2,3d]pyrimidine compositions and their use | ADORA3, ADORA2A, ADORA1 | KMT2A 1854/4885RAB9A 1426/4885ALDH1A1 1671/4885 |
| US-20080070936-A1 | Compounds specific to adenosine A1 receptors and uses thereof | ADORA1, ADORA2A, ADORA3 | KMT2A 2532/4885RAB9A 1884/4885ALDH1A1 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.